Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Papillomavirus Infections × Delivery of Health Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1 Prostatic Neoplasms 1 Papillomavirus Infections 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 38 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 30 Papillomavirus Vaccines 24 Vaccines 11 Human Papillomavirus Recombinant Vaccine nonavalent 10 Data Collection 9 Colposcopy 9 Blood Specimen Collection 9 Specimen Handling 7 Radiotherapy, Intensity-Modulated 7 Human Papillomavirus DNA Tests 7 Cisplatin 7 Carboplatin 6 Vaginal Smears 5 Vaccines, Synthetic 5 Educational Status 5 Early Intervention, Educational 5 Surveys and Questionnaires 4 Methods 4 Engerix-B 4 fludarabine 3 artesunic acid 3 artemisinin 3 Watchful Waiting 3 Polymerase Chain Reaction 3 Paclitaxel 3 Observation 3 Imiquimod 3 Hepatitis A Vaccines 3 Cyclophosphamide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04660331 2024-10-09

PROMOTE

Fred Hutchinson Cancer Center

Phase NA Completed

42 enrolled 14 charts

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡